EQUITY-BASED COMPENSATION - Schedule of Stock-based Compensation Arrangements (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Nov. 30, 2024	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity-Based Compensation Expense		$ 21,733	$ 6,006	$ 1,638
Remaining Expense To Be Recognized, If All Vesting Conditions Are Met		$ 52,034
Options
Options outstanding, beginning balance (in shares)		102,343	112,343
Granted (in shares)		0
Less: exercised/vested (in shares)		10,000
Less: forfeited and canceled (in shares)		0
Options outstanding, ending balance (in shares)		102,343	112,343
Weighted Average Exercise/Issuance Price
Options outstanding (in dollars per share)			$ 52.70
Granted (in dollars per share)		$ 0
Less: exercised/vested (in dollars per share)		14.77
Less: forfeited and canceled (in dollars per share)		0
Weighted Average Issuance Price
Less: exercised/vested (in dollars per share)		0
Less: forfeited/canceled (in dollars per share)		$ 0
Stock Options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity-Based Compensation Expense		$ 508	$ 296	0
Remaining Expense To Be Recognized, If All Vesting Conditions Are Met		$ 1,270
Weighted Average Remaining Contractual Term (in years)		7 years 8 months 12 days
Weighted Average Exercise/Issuance Price
Options outstanding (in dollars per share)		$ 56.37
Aggregate intrinsic value (in thousands)		$ 14,377
Weighted average remaining contractual term (in years)		7 years 8 months 12 days
Restricted shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity-Based Compensation Expense		$ 7,448	$ 3,756	1,638
Remaining Expense To Be Recognized, If All Vesting Conditions Are Met		$ 14,012
Weighted Average Remaining Contractual Term (in years)		1 year 8 months 12 days
Shares
Outstanding, beginning balance (in shares)		481,138
Granted (in shares)		51,898
Less: exercised/vested (in shares)		23,712
Less: forfeited/cancelled (in shares)		0
Outstanding, ending balance (in shares)		509,324	481,138
Weighted Average Issuance Price
Outstanding (in dollars per share)		$ 48.60	$ 41.90
Granted (in dollars per share)		128.98
Less: exercised/vested (in dollars per share)		88.54
Less: forfeited/canceled (in dollars per share)		$ 0
Aggregate intrinsic value		$ 24,753
Weighted average remaining contractual term (in years)		1 year 8 months 12 days
Performance shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity-Based Compensation Expense		$ 13,777	$ 1,954	$ 0
Remaining Expense To Be Recognized, If All Vesting Conditions Are Met		$ 36,752
Weighted Average Remaining Contractual Term (in years)		2 years 9 months 18 days
Shares
Outstanding, beginning balance (in shares)		1,000,000
Granted (in shares)	1,000,000	28,441
Less: exercised/vested (in shares)		0
Less: forfeited/cancelled (in shares)		0
Outstanding, ending balance (in shares)		1,028,441	1,000,000
Weighted Average Issuance Price
Outstanding (in dollars per share)		$ 51.03	$ 48.11
Granted (in dollars per share)		$ 153.80
Weighted average remaining contractual term (in years)		2 years 9 months 18 days